Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrovirus Epidemiology Donor Study-II (REDS-II)

NCT00097006 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00097006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00097006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrovirus Epidemiology Donor Study-II (REDS-II)
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Completed
Start date
September 30, 2004
Completion date
September 30, 2009
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acquired immunodeficiency syndrome, blood donors, blood transfusion, hepacivirus, hepatitis b, hepatitis, viral, human, hiv infections, hiv-1, hiv-2, htlv-i, htlv-ii, retroviridae infections, west nile virus